ADVERTISEMENT

From the Desk of the CEO

James Keagy
/ Categories: CEO Blog

Remembering pharmacy icon Peter Vlasses

On August 1, 2026, pharmacy lost another of our trailblazers, Peter Vlasses, former ACPE executive director. As I learned this news, I was reminded that Pete was the 2022 Remington Honor Medalist, earning the profession’s highest honor. This prompted me to go back and read what Pete had to say when delivering his Remington Address. Remington Honor Medal speeches are inspiring, particularly in retrospect since nearly all of the recipients of this medal, like Pete, were trailblazers, even if they didn’t realize it at the time. I knew Pete quite well over the entirety of my career and his life offered profound lessons to consider.

Pete knew where he came from, and he was very proud of it. Pete’s father was from Ithaca, Greece, and that heritage came out frequently in conversations and was evident in his writings. This legacy was important to Pete, because language was a vehicle to express more eloquently the heartfelt passion he had for his profession, giving Pete meaning and purpose. His Remington Address perfectly illustrates this as he contemplates his father’s favorite Greek word “metamorphosis.” The word suggests profound change—a complete transformation. It invites us to consider whether the pharmacist’s role is undergoing its own caterpillar-to-butterfly metamorphosis. The term does not imply speed or timing, only transformation. Pete’s reminder encourages us all to press on.

Pete was also what many of us would call an early adopter. The concept of early adopters comes from a sociologist, Everett Rogers, who described how new innovations are taken up by a society as a part of social change. When Apple released the iPhone, how fast did I ditch my Blackberry device and flip phone to make the switch? Some of us like to wait for innovations to see how things turn out, yet others are wired to take advantage and embrace a change or shift that is happening. Early adopters of pharmaceutical care provided clinical care in community pharmacies in the 1990s when Doug Helpler and Linda Strand introduced the concept. Now over 30 years later, we are trying to achieve the tipping point of widespread standard of care clinical practice. Pete’s work and life remind us that our profession desperately needs more early adopters to lean in and take risks.

Finally, Pete taught us a bit about loving and appreciating ourselves. Sometimes we are intensely hard on ourselves. We see the challenges, work through them, and then criticize ourselves for perceived mistakes or something we could have done better. I’m reminded of the adage that we should not allow perfect to get in the way of the good. Pete did a lot of good in his life. He took many risks as an individual and, in the process, led our profession: one of the most impactful included changes in our doctoral education standards. He also was chairman of the Board of Directors of the Board of Pharmacy Specialties early in its history when we were still trying to decide as a profession if specialists had a place! Now there are over 60,000 BPS-certified specialists.

Pete was president of the American College of Clinical Pharmacy, leading where he thought pharmacy was headed and not focused so much on where it had been in the past. In every leadership position, every role he had in teaching student pharmacists and leading ACPE, Pete always challenged us to think bigger and act more boldly. He understood that metamorphosis in pharmacy would require this. In Pete’s words, “When pervasive change in all sectors of pharmacy practice occurs (and it will!), professional colleagues, patients, and their families will know pharmacists better and love us even more.”

Well done, Pete. Thank you for blazing the trails.

For all of pharmacy.

Previous Article HRSA’s proposed 340B rebate pilot risks disrupting pharmacist-provided care
Next Article Remembering September 11, 2001
Print
1631
Please login or register to post comments.

Featured Post

Posted: Mar 10, 2026

Lessons from Coach Lou Holtz

APhA CEO Michael Hogue reflects on the wisdom of legendary football coach Lou Holt, while encouraging pharmacy professionals to consider how the coach’s words may impact their role in the profession.

All Posts

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Posted: Aug 12, 2026

Remembering pharmacy icon Peter Vlasses

On August 1, 2026, pharmacy lost another of our trailblazers, Peter Vlasses, former ACPE executive director. As I learned this news, I was reminded that Pete was the 2022 Remington Honor Medalist, earning the profession’s highest honor.

Posted: Aug 5, 2026

HRSA’s proposed 340B rebate pilot risks disrupting pharmacist-provided care

Pharmacists, regardless of practice setting, are well aware of the impact of the 340B program on pharmacy revenue. For student pharmacists and others who may not have encountered this program before, you can get a crash course on the history of the program from its origins in 1992 and how it currently operates at the Health Resources & Service Administration’s (HRSA’s) website.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Posted: Apr 30, 2026

Redefining Possible: A personal reflection on passion, purpose, and joy

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP, President, APhA

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP—in her first blog as APhA President—reflects on the values that continue to shape the future of pharmacy: passion, purpose, and joy.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement